AVEO PHARMACEUTICALS INC (AVEO)
US0535883070 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.04M | -53.34M | -35.58M | 9.39M | -5.33M | |||
| Depreciation Amortization | 67.00K | 67.00K | 20.00K | N/A | 0.00 | |||
| Change In Working Capital | -294.00K | -10.01M | -240.00K | -3.61M | -2.22M | |||
| Interest Paid | 3.97M | 2.89M | 1.34M | 1.97M | 1.99M | |||
| Other non cash items | 6.61M | 6.03M | -2.18M | -8.70M | -17.48M | |||
| OPERATING CASH FLOW | -22.66M | -57.26M | -37.98M | -2.92M | -25.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -360.00K | N/A | N/A | |||
| Other Investing Activity | 25.10M | -16.87M | 18.07M | -17.92M | 18.58M | |||
| INVESTING CASH FLOW | 25.10M | -16.87M | 17.70M | -17.92M | 18.58M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 5.00M | 25.00M | -1.17M | -3.83M | 0.00 | |||
| Stock Issued/Repurchased | 1.12M | 58.78M | 53.68M | 30.33M | 16.47M | |||
| Other Financing Activity | 0.00 | -875.00K | -260.00K | -300.00K | -540.00K | |||
| FINANCING CASH FLOW | 6.12M | 82.90M | 52.26M | 26.19M | 15.93M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 8.56M | 8.78M | 31.98M | 5.35M | 9.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.66M | -57.26M | -37.98M | -2.92M | -25.03M | |||
| Capital Expenditure | N/A | 0.00 | -360.00K | N/A | N/A | |||
| FREE CASH FLOW | -22.66M | -57.26M | -38.34M | -2.92M | -25.03M | |||
All data in USD